Literature DB >> 1192578

Current concepts of "normal values," "reference values," and "discrimination values," in clinical chemistry.

F W Sunderman.   

Abstract

The term "normal values" is seriously afflicted by sylleptic ambiguities and conceptual problems, and it is gradually being discarded from the lexicon of clinical chemistry. The neutral term "reference values" preferable on semantic and scientific grounds, and its use in clinical chemistry is rapidly gaining acceptance. The term "discrimination value" has been added to the lexicon of clinical chemistry. Use of the "discrimination value" for the results of a laboratory test in a specified clinical situation provides the optimal discrimination between the "healthy" and the "diseased," or between "those who need not be investigated further" and "those who do."

Mesh:

Year:  1975        PMID: 1192578

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  29 in total

1.  Time-varying limits for single blood pressures and heart rates of group-synchronized healthy women.

Authors:  K Otsuka; G Cornélissen; H Watanabe; S C Hunt; F Halberg
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

2.  Heat map visualization of high-density clinical chemistry data.

Authors:  J Todd Auman; Gary A Boorman; Ralph E Wilson; Gregory S Travlos; Richard S Paules
Journal:  Physiol Genomics       Date:  2007-07-24       Impact factor: 3.107

3.  Hematology and biochemistry reference values for the ranch fox.

Authors:  D M Benn; D B McKeown; J H Lumsden
Journal:  Can J Vet Res       Date:  1986-01       Impact factor: 1.310

Review 4.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

5.  Determining clinical significance in repeated laboratory measurements. The "Clinical Delta Range".

Authors:  D Lezotte; R R Grams
Journal:  J Med Syst       Date:  1979       Impact factor: 4.460

Review 6.  Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Trends Cardiovasc Med       Date:  2016-07-28       Impact factor: 6.677

7.  ROC analysis in radioimmunoassay: an application to the interpretation of thyroglobulin measurement in the follow-up of thyroid carcinoma.

Authors:  P Hannequin; J C Liehn; M J Delisle; G Deltour; J Valeyre
Journal:  Eur J Nucl Med       Date:  1987

8.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

9.  Hypertension increases with aging and obesity in chimpanzees (Pan troglodytes).

Authors:  John J Ely; Tony Zavaskis; Michael L Lammey
Journal:  Zoo Biol       Date:  2012-09-11       Impact factor: 1.421

10.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.